A.M. Vitals: J&J Nears Settlement With Justice Dept.

by Blogburger on June 21, 2012

Johnson & Johnson and Justice are close to settling a protracted investigation into promotion of the antipsychotic Risperdal, for what would be one of the highest sums to date in a drug-marketing case, according to people familiar with the matter. The sides are trying to wrap together lawsuits, state investigations and other probes, and are discussing a payment of at least $ 1.5 billion, some of the people said.




Health Blog

Comments on this entry are closed.

Previous post:

Next post: